Department of Economics, School of Business, Marquette University, Milwaukee, WI 53005, USA.
Med Care. 2013 Apr;51(4 Suppl 2):S47-52. doi: 10.1097/MLR.0b013e3182849fb4.
Decisions of health care institutions to invest in nursing care are often guided by mixed and conflicting evidence of effects of the investments on organizational function and sustainability. This paper uses new evidence generated through Interdisciplinary Nursing Quality Research Initiative (INQRI)-funded research and published in peer-reviewed journals, to illustrate where the business case for nursing investments stands and to discuss factors that may limit the existing evidence and its transferability into clinical practice. We conclude that there are 3 limiting factors: (1) the existing business case for nursing investments is likely understated due to the inability of most studies to capture spillover and long-run dynamic effects, thus causing organizations to forfeit potentially viable nursing investments that may improve long-term financial stability; (2) studies rarely devote sufficient attention to describing the content and the organization-specific contextual factors, thus limiting generalizability; and (3) fragmentation of the current health care delivery and payment systems often leads to the financial benefits of investments in nursing care accruing outside of the organization incurring the costs, thus making potentially quality-improving and cost-saving interventions financially unattractive from the organization's perspective. The payment reform, with its emphasis on high-quality affordable patient-centered care, is likely to strengthen the business case for investments in nursing care. Methodologically rigorous approaches that focus on broader societal implications of investments in nursing care, combined with a thorough understanding of potential barriers and facilitators of nursing change, should be an integral part of future research and policy efforts.
医疗机构投资于护理的决策往往受到混合和相互矛盾的证据的影响,这些证据涉及投资对组织功能和可持续性的影响。本文利用通过跨学科护理质量研究倡议(INQRI)资助的研究产生的新证据,并发表在同行评议的期刊上,说明护理投资的商业案例的现状,并讨论可能限制现有证据及其在临床实践中的可转移性的因素。我们得出结论,有 3 个限制因素:(1)由于大多数研究无法捕捉溢出效应和长期动态效应,因此护理投资的现有商业案例可能被低估,从而导致组织放弃可能改善长期财务稳定性的潜在可行的护理投资;(2)研究很少充分关注描述内容和特定于组织的背景因素,因此限制了可推广性;(3)当前医疗保健提供和支付系统的碎片化常常导致护理投资的财务收益在产生成本的组织之外产生,从而使从组织角度来看可能提高质量和节省成本的干预措施在财务上没有吸引力。以高质量、负担得起的以患者为中心的护理为重点的支付改革,可能会增强护理投资的商业案例。关注护理投资的更广泛的社会影响的方法严谨的方法,结合对护理变革的潜在障碍和促进因素的透彻理解,应该成为未来研究和政策努力的一个组成部分。